GeneID: 444



Names

Common Name: IGSF4 Type: Gene
Chromosome: 11 (NC_000011.10) Locus: NM_001301043.2 (CADM1)
HUGO Symbol: CADM1 Full Name: cell adhesion molecule 1
Exons: 12 Introns: 11

Description:
The IGSF4 gene encodes a cell adhesion molecule as a member of immunoglobulin superfamily 4, and plays a major role in globin synthesis through its involvement in globin expression regulation. The promoter of the IGSF4 gene (containing 12 CpG sites) is highly methylated (thus inactivated) and the expression of IGSF4 gene is markedly down-regulated in thalassaemia patients compared to healthy controls. IGSF4 could be a potential modifier of β-thalassaemia severity and a candidate biomarker for non-invasive prenatal diagnosis and clinical classification of thalassaemia.

Synonyms: BL2 , ST17 , NECL2 , RA175 , TSLC1 , IGSF4A , Necl-2 , SYNCAM , sgIGSF , sTSLC-1 , synCAM1

Comments:
N/A

Sequence Viewer

Note: The NCBI Sequence Viewer is not installed on the ITHANET servers but it is embedded in this page from the NCBI. Therefore, IthaGenes has no responsibility over any temporary unavailability of the service. In such a case, please Refresh the page or retry at a later stage.

Publications / Origin

  1. Gao T, Nie Y, Hu H, Liang Z, Hypermethylation of IGSF4 gene for noninvasive prenatal diagnosis of thalassemia., Med Sci Monit, 18(1), BR33-40, 2012 PubMed
  2. Zakaria NA, Islam MA, Abdullah WZ, Bahar R, Mohamed Yusoff AA, Abdul Wahab R, Shamsuddin S, Johan MF, Epigenetic Insights and Potential Modifiers as Therapeutic Targets in -Thalassemia., Biomolecules, 11(5), 0, 2021 PubMed
Created on 2021-08-19 09:52:15, Last reviewed on 2021-08-19 09:53:25 (Show full history)


Disclaimer: The information on this website is provided as an information resource only and must not to be used as a substitute for professional diagnosis and treatment. The ITHANET Portal and IthaGenes are not responsible or liable for any advice, course of treatment, diagnosis or any other information, services or products that an individual obtains through this website.